CRISPR-Cas9 Globin Editing Can Induce Megabase-Scale Copy-Neutral Losses of Heterozygosity in Hematopoietic Cells

In primary hematopoietic progenitor/stem cells, researchers detected 1.1% of clones with acquired megabase losses of heterozygosity induced by CRISPR-Cas9.